X-134807658-C-A
Variant summary
Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001388447.1(PABIR3):c.60C>A(p.Asp20Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000472 in 1,206,355 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 16 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001388447.1 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PABIR3 | NM_001388447.1 | c.60C>A | p.Asp20Glu | missense_variant | Exon 2 of 11 | ENST00000645433.2 | NP_001375376.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PABIR3 | ENST00000645433.2 | c.60C>A | p.Asp20Glu | missense_variant | Exon 2 of 11 | NM_001388447.1 | ENSP00000496338.1 |
Frequencies
GnomAD3 genomes AF: 0.00000895 AC: 1AN: 111711Hom.: 0 Cov.: 23 show subpopulations
GnomAD2 exomes AF: 0.0000222 AC: 4AN: 180226 AF XY: 0.0000463 show subpopulations
GnomAD4 exome AF: 0.0000512 AC: 56AN: 1094644Hom.: 0 Cov.: 30 AF XY: 0.0000444 AC XY: 16AN XY: 360346 show subpopulations
GnomAD4 genome AF: 0.00000895 AC: 1AN: 111711Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 33917 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.60C>A (p.D20E) alteration is located in exon 1 (coding exon 1) of the FAM122C gene. This alteration results from a C to A substitution at nucleotide position 60, causing the aspartic acid (D) at amino acid position 20 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at